The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their position as middlemen in the U.S. drug s… [+3583 chars]Read More
FTC sues pharmacy insurance managers alleging unfair drug prices The Washington Post
